BLLN Stock Summary and Trading Ideas (Billiontoone - Class A | NASDAQ:BLLN)

BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.

What symbol and exchange does Billiontoone - Class A shares trade?

Billiontoone - Class A trades on the NASDAQ stock market under the symbol BLLN.

What is Billiontoone - Class A stock price doing today?

As of December 8, 2025, BLLN stock price declined to $104.66 with 209,029 million shares trading.

How much is Billiontoone - Class A worth?

BLLN has a market cap of $4.75 billion. This is considered a Mid Cap stock.

What are the top ETFs holding Billiontoone - Class A?

The top ETF exchange traded funds that BLLN belongs to (by Net Assets): ONEQ, LFSC, TMSL, BOUT.

What are the support and resistance levels for Billiontoone - Class A (BLLN)?

BLLN support price is $102.43 and resistance is $120.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLLN shares will trade within this expected range on the day.